RC

Rangeley Capital Portfolio holdings

AUM $92.6M
1-Year Est. Return 77.32%
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
+77.32%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$116M
AUM Growth
+$9.59M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
169
New
Increased
Reduced
Closed

Top Buys

1 +$5.43M
2 +$5.05M
3 +$3.49M
4
KW icon
Kennedy-Wilson Holdings
KW
+$3.07M
5
GRND icon
Grindr
GRND
+$2.88M

Top Sells

1 +$4.89M
2 +$3.71M
3 +$3.27M
4
KROS icon
Keros Therapeutics
KROS
+$2.84M
5
SGRY icon
Surgery Partners
SGRY
+$2.68M

Sector Composition

1 Healthcare 33.98%
2 Real Estate 10.72%
3 Consumer Discretionary 9.78%
4 Communication Services 9.69%
5 Technology 8.87%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAAQ
101
Real Asset Acquisition Corp
RAAQ
$270M
$102K 0.09%
+10,000
SITC icon
102
SITE Centers
SITC
$256M
$89.9K 0.08%
14,000
SHCO
103
DELISTED
Soho House & Co
SHCO
$89.6K 0.08%
10,000
-83,200
ANTX icon
104
AN2 Therapeutics
ANTX
$147M
$74.1K 0.06%
65,000
NKTX icon
105
Nkarta
NKTX
$192M
$59.3K 0.05%
+32,078
BRNS
106
Barinthus Biotherapeutics
BRNS
$28.6M
$59.1K 0.05%
+84,441
VYNE icon
107
VYNE Therapeutics
VYNE
$21.9M
$58K 0.05%
100,000
+50,000
PMVP icon
108
PMV Pharmaceuticals
PMVP
$61.9M
$56.9K 0.05%
45,500
ANEB
109
DELISTED
Anebulo Pharmaceuticals
ANEB
$50.5K 0.04%
50,000
+30,000
MGNX icon
110
MacroGenics
MGNX
$264M
$48.7K 0.04%
30,220
SEER icon
111
Seer Inc
SEER
$102M
$36.6K 0.03%
20,000
AIFC
112
AI Financial Corp
AIFC
$110M
$31.9K 0.03%
29,000
-19,300
RLYB icon
113
Rallybio
RLYB
$92.9M
$27.4K 0.02%
5,000
-5,376
EMISR
114
Emmis Acquisition Corp Rights
EMISR
$18.1K 0.02%
+18,107
MLACR
115
Mountain Lake Acquisition Corp Right
MLACR
$15.6K 0.01%
+15,000
AIV
116
Aimco
AIV
$616M
-15,000
AMPY icon
117
Amplify Energy
AMPY
$195M
-10,000
FRMM
118
Forum Markets
FRMM
$70.8M
-1,000
NATH icon
119
Nathan's Famous
NATH
$413M
-5,410
NERV icon
120
Minerva Neurosciences
NERV
$216M
-10,000
NKTR icon
121
Nektar Therapeutics
NKTR
$2.01B
-4,895
NRP icon
122
Natural Resource Partners
NRP
$1.39B
-12,100
ODP
123
DELISTED
ODP
ODP
-15,337
REPL icon
124
Replimune Group
REPL
$815M
-10,400
SCPH
125
DELISTED
scPharmaceuticals
SCPH
-93,747